These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12068162)

  • 1. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions.
    Kalinowski M; Alfke H; Kleb B; Dürfeld F; Joachim Wagner H
    Invest Radiol; 2002 Jul; 37(7):399-404. PubMed ID: 12068162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study.
    Song TJ; Lee SS; Yun SC; Park DH; Seo DW; Lee SK; Kim MH
    Gastrointest Endosc; 2011 Apr; 73(4):727-33. PubMed ID: 21288514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract.
    Jang SI; Jeong S; Lee DH; Na K; Yang S; Lee DK
    Gut Liver; 2019 Apr; 13(4):471-478. PubMed ID: 30970427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane.
    Jang SI; Kim JH; Kim M; Yang S; Jo EA; Lee JW; Na K; Kim JM; Jeong S; Lee DH; Lee DK
    Endoscopy; 2012 Sep; 44(9):825-31. PubMed ID: 22752887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
    Suk KT; Kim JW; Kim HS; Baik SK; Oh SJ; Lee SJ; Kim HG; Lee DH; Won YH; Lee DK
    Gastrointest Endosc; 2007 Oct; 66(4):798-803. PubMed ID: 17905025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety evaluation of paclitaxel-loaded metal stents in patients with malignant biliary obstructions.
    Yuan T; Zhu Y; Wang X; Cui W; Cao J
    Eur J Surg Oncol; 2019 May; 45(5):816-819. PubMed ID: 30389299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of paclitaxel on the growth of normal, polyposis, and cancerous human colonic epithelial cells.
    Sheppard BC; Rutten MJ; Meichsner CL; Bacon KD; Leonetti PO; Land J; Crass RC; Trunkey DD; Deveney KE; Deveney CW
    Cancer; 1999 Apr; 85(7):1454-64. PubMed ID: 10193934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane.
    Lee DK; Kim HS; Kim KS; Lee WJ; Kim HK; Won YH; Byun YR; Kim MY; Baik SK; Kwon SO
    Gastrointest Endosc; 2005 Feb; 61(2):296-301. PubMed ID: 15729251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of paclitaxel-eluting metal stents in renal artery of pig model.
    Voudoukis T; Liatsikos EN; Kagadis GC; Christeas N; Flaris N; Katsanos K; Costantinides C; Perimenis P; Scopa CD; Filos KS; Nikiforidis GC; Alexopoulos D; Siablis D
    J Endourol; 2007 Dec; 21(12):1571-6. PubMed ID: 18044994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of mitomycin C and paclitaxel on the proliferation and apoptosis of human pulmonary fibroblast].
    Chen N; Zhang J; Xu M; Wang T; Wang YL; Pei YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Sep; 36(9):655-60. PubMed ID: 24423818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro.
    Michalakis J; Georgatos SD; de Bree E; Polioudaki H; Romanos J; Georgoulias V; Tsiftsis DD; Theodoropoulos PA
    Ann Surg Oncol; 2007 Mar; 14(3):1220-8. PubMed ID: 17206477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model.
    Zhang Y; Ma L; Huang J; Shuang J; Chen J; Fan Z
    PLoS One; 2017; 12(3):e0173262. PubMed ID: 28253360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue.
    Jeong D; Lee DH; Lee DK; Na K
    J Biomater Appl; 2015 Mar; 29(8):1133-44. PubMed ID: 25252589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
    Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell lines.
    Riccardi A; Servidei T; Tornesello A; Puggioni P; Mastrangelo S; Rumi C; Riccardi R
    Eur J Cancer; 1995; 31A(4):494-9. PubMed ID: 7576952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
    Reinecke P; Knopf C; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer; 2000 Apr; 88(7):1614-22. PubMed ID: 10738220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.
    Taylor CW; Wang LM; List AF; Fernandes D; Paine-Murrieta GD; Johnson CS; Capizzi RL
    Eur J Cancer; 1997 Sep; 33(10):1693-8. PubMed ID: 9389935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells.
    Belotti D; Rieppi M; Nicoletti MI; Casazza AM; Fojo T; Taraboletti G; Giavazzi R
    Clin Cancer Res; 1996 Oct; 2(10):1725-30. PubMed ID: 9816123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.